H.R. 2591 (119th)Bill Overview

Mental Health in Aviation Act of 2025

Transportation and Public Works|Administrative law and regulatory proceduresAviation and airports
Cosponsors
Support
Bipartisan
Introduced
Apr 2, 2025
Discussions
Bill Text
Current stageCommittee

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

The Mental Health in Aviation Act of 2025 directs the FAA to revise regulations to encourage aviation personnel to seek mental health care and to disclose mental health conditions.

It requires consultation with stakeholders, implementation (or congressional justification for non-implementation) of report and rulemaking recommendations, annual reviews of special issuance policies (including medication approvals and AME training), set‑asides from existing FAA funds for additional aviation medical examiners and backlog reduction, and a small public education campaign to destigmatize help‑seeking.

Deadlines include updates within two years, implementation actions within 180 days of a required report, and set funding actions for fiscal years 2026–2028.

Passage75/100

Narrow, safety‑oriented, modest cost, built‑in stakeholder consultation; typical of bills that clear committees and the floor with bipartisan support.

CredibilityAligned

Relative to its intended legislative type, this bill translates policy objectives into enforceable regulatory and administrative directives with specified timelines, stakeholder consultations, and targeted funding, but leaves substantive regulatory drafting, detailed operational safeguards, and performance metrics to subsequent rulemaking and implementation.

Contention65/100

Progressives emphasize destigmatization and access improvements.

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Targeted stakeholdersTargeted stakeholders
Likely helped
  • Targeted stakeholdersMay increase pilots' and controllers' willingness to seek mental health care, improving clinician access.
  • Targeted stakeholdersCould reduce certification backlogs through funded hiring, training, and delegations to more aviation medical examiners.
  • Targeted stakeholdersMay broaden approved medications and treatments available to airmen under special issuance rules.
Likely burdened
  • Targeted stakeholdersEncouraging disclosure could raise privacy and employment-consequence concerns among airmen.
  • Targeted stakeholdersDelegating additional authority to aviation medical examiners may raise concerns about inconsistent medical decision-ma…
  • Targeted stakeholdersMandates and reporting requirements may increase administrative and compliance burdens for FAA and stakeholders.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize destigmatization and access improvements.
Progressive85%

Likely broadly supportive because the bill reduces stigma, expands access to care, and invests in medical examiner capacity.

It aligns with values of worker safety, mental‑health parity, and proactive federal action, though advocates may want stronger privacy and anti‑discrimination safeguards.

Leans supportive
Centrist70%

Generally favorable but pragmatic: supports stigma reduction and backlog relief while watching safety, cost, and implementation details.

Will want clear metrics, phased rollout, and cost accountability before full endorsement.

Leans supportive
Conservative30%

Likely skeptical: supports destigmatizing care in principle but worries regulatory changes might weaken safety, expand federal control over medical decisions, or substitute policy for operational safety.

Emphasis would be on preserving strict fitness standards and FAA authority.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood75/100

Narrow, safety‑oriented, modest cost, built‑in stakeholder consultation; typical of bills that clear committees and the floor with bipartisan support.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • Scope of ‘‘reclassify and approve’’ medications and safety thresholds
  • Precise availability and legal status of referenced 106(k)(1) funding
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize destigmatization and access improvements.

Narrow, safety‑oriented, modest cost, built‑in stakeholder consultation; typical of bills that clear committees and the floor with bipartis…

Unlocked analysis

Relative to its intended legislative type, this bill translates policy objectives into enforceable regulatory and administrative directives with specified timelines, stakeholder consultations, and targeted funding, but…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis